Sponsors will now be able to submit preclinical toxicology data using virtual animal controls instead of a standard animal ...
The EU medicines regulator has backed a proposal designed to reduce the use of animals in medicines development by replacing ...
Following the trend of other regulators, the European Medicines Agency (EMA) is taking steps to reduce the need for animal testing. The agency has issued a draft qualification opinion for a new ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
MedPage Today on MSN
FDA proposes more flexibility in alternatives to animal testing in drug development
Non-animal testing methods could save drugmakers time and money, officials say ...
AI-based approaches are increasingly capturing complex human disease biology directly, without the use of potentially confounding animal models. [ignatiev / Getty Images] The recent decision by the ...
VivoSim Labs has launched non-animal toxicology models to enhance drug development, aligning with FDA's initiative to phase out animal testing. VivoSim Labs, Inc. has officially launched after ...
The VICT3R project is expanding its consortium by adding new beneficiaries and organisations to the network of contract research organisations (CROs) associated with the project. This expansion ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results